OpenPV Signal Explorer
FAERS disproportionality dashboard
← All drugs
Drug

Artificial Tears

123 flagged reaction(s) · 2,764 total co-reports · max PRR 51.6
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Eye Pain 342 51.6 59.5 signal
2 Ocular Discomfort 56 42.9 43.9 signal
3 Eye Irritation 243 36.3 40.0 signal
4 Photophobia 71 31.6 32.5 signal
5 Product Use Complaint 52 27.9 28.4 signal
6 Eye Discharge 29 23.6 23.8 signal
7 Lacrimation Increased 84 23.3 24.1 signal
8 Eye Inflammation 26 22.9 23.1 signal
9 Ocular Hyperaemia 116 20.6 21.6 signal
10 Dry Eye 107 18.3 19.1 signal
11 Eye Swelling 69 15.5 15.9 signal
12 Vitreous Floaters 17 14.5 14.6 signal
13 Impaired Quality Of Life 23 13.3 13.4 signal
14 Intraocular Pressure Increased 20 12.9 13.0 signal
15 Eye Pruritus 51 12.8 13.1 signal
16 Eyelid Oedema 15 10.6 10.7 signal
17 Ear Discomfort 13 10.5 10.6 signal
18 Eye Infection 14 10.3 10.4 signal
19 Visual Acuity Reduced 37 9.2 9.3 signal
20 Product Administration Error 22 9.1 9.2 signal
21 Vision Blurred 147 8.9 9.4 signal
22 Neutrophil Count Increased 11 8.9 8.9 signal
23 Hospice Care 10 8.4 8.4 signal
24 Blood Urea Increased 17 8.4 8.4 signal
25 Tinnitus 45 8.1 8.2 signal
26 Ear Pain 19 8.1 8.2 signal
27 Blood Thyroid Stimulating Hormone Increased 9 8.1 8.1 signal
28 Eyelid Ptosis 9 7.3 7.4 signal
29 Seasonal Allergy 12 7.0 7.1 signal
30 Discomfort 46 6.3 6.4 signal
31 Hyperlipidaemia 9 6.2 6.2 signal
32 Malnutrition 8 6.0 6.0 signal
33 Haemorrhoids 14 5.9 6.0 signal
34 Mitral Valve Incompetence 8 5.9 5.9 signal
35 Eye Disorder 23 5.8 5.9 signal
36 Cataract 41 5.7 5.8 signal
37 Haematocrit Decreased 13 5.4 5.4 signal
38 Blood Alkaline Phosphatase Increased 16 5.3 5.4 signal
39 Oesophagitis 7 5.3 5.3 signal
40 Device Use Issue 11 5.3 5.3 signal
41 Sleep Apnoea Syndrome 12 5.2 5.2 signal
42 Hypoxia 22 5.2 5.2 signal
43 Glaucoma 12 5.2 5.2 signal
44 Diplopia 16 5.1 5.1 signal
45 Leukocytosis 11 5.0 5.1 signal
46 Madarosis 7 5.0 5.0 signal
47 Economic Problem 9 4.8 4.9 signal
48 Hyperbilirubinaemia 6 4.8 4.8 signal
49 Glomerular Filtration Rate Decreased 7 4.8 4.8 signal
50 Small Intestinal Obstruction 7 4.7 4.7 signal
51 Retinal Detachment 5 4.5 4.5 signal
52 Mental Status Changes 15 4.5 4.5 signal
53 Hiatus Hernia 7 4.5 4.5 signal
54 Deformity 5 4.4 4.4 signal
55 Visual Impairment 65 4.4 4.5 signal
56 Incorrect Product Storage 7 4.4 4.4 signal
57 Eye Haemorrhage 7 4.3 4.3 signal
58 Uveitis 7 4.3 4.3 signal
59 Glycosylated Haemoglobin Increased 13 4.3 4.3 signal
60 Emotional Distress 62 4.2 4.3 signal
61 Disability 10 4.2 4.2 signal
62 Hypomagnesaemia 7 4.2 4.2 signal
63 Skin Ulcer 13 4.2 4.2 signal
64 Conjunctivitis 9 4.1 4.1 signal
65 Pharyngitis 6 4.0 4.0 signal
66 Coagulopathy 8 4.0 4.0 signal
67 Proteinuria 9 4.0 4.0 signal
68 Type 2 Diabetes Mellitus 16 3.9 3.9 signal
69 Therapy Partial Responder 7 3.9 3.9 signal
70 Body Height Decreased 5 3.8 3.8 signal
71 Platelet Count Increased 6 3.8 3.8 signal
72 Multi-organ Failure 8 3.8 3.8 signal
73 Sinus Disorder 9 3.8 3.8 signal
74 Blood Triglycerides Increased 8 3.7 3.7 signal
75 Rhinorrhoea 29 3.7 3.8 signal
76 Quality Of Life Decreased 6 3.7 3.7 signal
77 Sinus Congestion 6 3.7 3.7 signal
78 Scab 5 3.7 3.7 signal
79 Respiratory Tract Congestion 7 3.6 3.7 signal
80 Increased Tendency To Bruise 4 3.6 3.6 signal
81 Muscle Tightness 7 3.6 3.6 signal
82 Gastric Haemorrhage 5 3.6 3.6 signal
83 Carpal Tunnel Syndrome 6 3.5 3.5 signal
84 Sputum Discoloured 4 3.5 3.5 signal
85 Blindness 17 3.5 3.5 signal
86 Upper Gastrointestinal Haemorrhage 7 3.4 3.4 signal
87 Accidental Overdose 15 3.4 3.4 signal
88 Fluid Overload 6 3.4 3.4 signal
89 Therapy Interrupted 28 3.4 3.4 signal
90 Sneezing 9 3.3 3.3 signal
91 Cyst 5 3.3 3.3 signal
92 Rotator Cuff Syndrome 5 3.2 3.2 signal
93 Hip Fracture 12 3.1 3.1 signal
94 Red Blood Cell Sedimentation Rate Increased 4 3.0 3.0 no signal
95 Blindness Unilateral 5 2.9 2.9 signal
96 Impaired Driving Ability 4 2.9 2.9 no signal
97 Vasculitis 4 2.8 2.8 no signal
98 Macular Degeneration 4 2.8 2.8 no signal
99 Hallucination, Visual 7 2.8 2.8 signal
100 Acute Myeloid Leukaemia 5 2.7 2.7 no signal
101 Leukaemia 3 2.6 2.6 no signal
102 Laceration 3 2.6 2.6 no signal
103 Complication Associated With Device 4 2.5 2.5 no signal
104 Helicobacter Infection 3 2.4 2.4 no signal
105 Drug Toxicity 4 2.4 2.4 no signal
106 Inappropriate Schedule Of Drug Administration 20 2.3 2.3 signal
107 Anosmia 4 2.3 2.3 no signal
108 Product Packaging Quantity Issue 3 2.3 2.3 no signal
109 Wrong Technique In Product Usage Process 54 2.2 2.2 signal
110 Cytopenia 3 2.1 2.1 no signal
111 Lactic Acidosis 8 2.1 2.1 no signal
112 Muscle Spasticity 3 2.0 2.0 no signal
113 Blood Glucose Increased 45 2.0 2.0 no signal
114 Neurotoxicity 4 1.9 1.9 no signal
115 Cytokine Release Syndrome 4 1.7 1.7 no signal
116 Multiple Sclerosis 10 1.7 1.7 no signal
117 Injection Site Haematoma 3 1.7 1.7 no signal
118 Drug Dose Omission 28 1.4 1.4 no signal
119 Accidental Exposure To Product 14 1.2 1.2 no signal
120 Product Storage Error 12 1.1 1.1 no signal
121 Product Complaint 3 1.0 1.0 no signal
122 Needle Issue 3 0.9 0.9 no signal
123 Device Difficult To Use 5 0.6 0.6 no signal